Amgen Inc
(BSP:AMGN34)
R$
60.36
0.26 (0.43%)
Market Cap: 901.82 Bil
Enterprise Value: 1.20 Til
PE Ratio: 45.45
PB Ratio: 33.95
GF Score: 76/100 - Q1 2024 Amgen Inc Earnings Call TranscriptMay 02, 2024R$50.75 (-0.41%)Earnings
- Amgen Inc at TD Cowen Health Care Conference TranscriptMar 05, 2024
- Amgen Inc IR Call Rare Disease Investor Analyst Event TranscriptFeb 22, 2024
- Amgen Inc at Oppenheimer Healthcare Life Sciences Conference TranscriptFeb 14, 2024
- Q4 2023 Amgen Inc Earnings Call TranscriptFeb 06, 2024R$55.89 (-2.44%)Earnings
- Amgen Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Amgen Inc at Evercore ISI HealthCONx Conference TranscriptNov 29, 2023
- Q3 2023 Amgen Inc Earnings Call TranscriptOct 31, 2023R$45.8 (-3.54%)Earnings
- Amgen Inc ESMO Call TranscriptOct 24, 2023
- Amgen Inc at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 14, 2023
- Amgen Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Amgen Inc at Citi Global Healthcare Conference TranscriptSep 07, 2023
- Amgen Inc at Wells Fargo Healthcare Conference TranscriptSep 06, 2023
- Q2 2023 Amgen Inc Earnings Call TranscriptAug 03, 2023R$39.48Earnings
- Amgen Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Amgen Inc at TD Cowen Oncology Innovation Summit (Virtual) TranscriptMay 31, 2023
- Amgen Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Amgen Inc Earnings Call TranscriptApr 27, 2023R$42.61 (-1.11%)Earnings
- Amgen Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Amgen Inc at Cowen Health Care Conference TranscriptMar 08, 2023
- Amgen Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 14, 2023
- Q4 2022 Amgen Inc Earnings Call TranscriptJan 31, 2023R$45.55 (-0.81%)Earnings
- Amgen Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Amgen Inc To Acquire Horizon Therapeutics TranscriptDec 12, 2022
- Amgen Inc Investor Call TranscriptDec 05, 2022
- Amgen Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Amgen Inc at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- Amgen Inc Investor Call from AHA 2022 TranscriptNov 07, 2022
- Q3 2022 Amgen Inc Earnings Call TranscriptNov 03, 2022R$48.66 (-2.27%)Earnings
- Amgen Inc at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 15, 2022
- Amgen Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Amgen Inc Corporate Call TranscriptSep 12, 2022
- Amgen Inc at Wells Fargo Healthcare Conference TranscriptSep 08, 2022
- Amgen Inc at Citi BioPharma Conference TranscriptSep 07, 2022
- Amgen Inc Conference Call from 2022 World Conference on Lung Cancer (WCLC) TranscriptAug 08, 2022
- Q2 2022 Amgen Inc Earnings Call TranscriptAug 04, 2022R$46.17 (-1.47%)Earnings
- Amgen Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Amgen Inc at Jefferies Healthcare Conference TranscriptJun 08, 2022
- Amgen Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Amgen Inc Earnings Call TranscriptApr 27, 2022R$44.33 (-0.78%)Earnings
- Amgen Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 16, 2022
- Amgen Inc at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- Amgen Inc Business Review Meeting TranscriptFeb 08, 2022
- Amgen Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Amgen Inc at Goldman Sachs Healthcare CEOs Unscripted Conference: A View from the Top (Virtual) TranscriptJan 06, 2022
- Amgen Inc at Piper Sandler Healthcare Conference (Virtual) TranscriptDec 01, 2021
- Amgen Inc at Evercore ISI HealthCONx Virtual Conference TranscriptNov 30, 2021
- Amgen Inc at Cowen Immuno-Oncology Next Summit (Virtual) TranscriptNov 15, 2021
- Q3 2021 Amgen Inc Earnings Call TranscriptNov 02, 2021R$42.49Earnings
- Amgen Inc Call to Discuss Clinical Data Being Presented at EADV TranscriptOct 04, 2021
- Amgen Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 27, 2021
- Amgen Inc Call from European Society for Medical Oncology 2021 Congress TranscriptSep 16, 2021
- Amgen Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Amgen Inc at Citi BioPharma Conference (Virtual) TranscriptSep 08, 2021
- Q2 2021 Amgen Inc Earnings Call TranscriptAug 03, 2021R$45.09 (+2.38%)Earnings
- Amgen Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Amgen Inc Conference Call from ASCO TranscriptJun 04, 2021
- Amgen Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 03, 2021
- Amgen Inc and Kyowa Kirin Co Ltd Collaboration on KHK4083 and LUMAKRAS FDA Approval Conference Call TranscriptJun 01, 2021
- Amgen Inc at Cowen Virtual Oncology Innovation Summit TranscriptMay 21, 2021
- Amgen Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Q1 2021 Amgen Inc Earnings Call TranscriptApr 27, 2021R$50.08 (+0.30%)Earnings
- Amgen Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 16, 2021
- Amgen Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 04, 2021
- Amgen Inc M&A Call on Five Prime Therapeutics Inc Acquisition TranscriptMar 04, 2021
- Amgen Inc Investor Conference Call from American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting TranscriptFeb 26, 2021
- Amgen Inc at Guggenheim Partners Healthcare Talks Oncology Days TranscriptFeb 12, 2021
- Q4 2020 Amgen Inc Earnings Call TranscriptFeb 02, 2021R$46.22 (-1.66%)Earnings
- Amgen Inc WCLC Data Highlights Investor Call TranscriptJan 30, 2021
- Amgen Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Amgen Inc at Milken Institute Asia Summit TranscriptDec 09, 2020
- Amgen Inc Post ASH 2020 Oncology Update TranscriptDec 08, 2020
- Amgen Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2020
- Amgen Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 18, 2020
- Amgen Inc at Cowen Immuno-Oncology Next Summit TranscriptNov 13, 2020
- Amgen Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2020
- Q3 2020 Amgen Inc Earnings Call TranscriptOct 28, 2020R$44.79 (-1.65%)Earnings
- Amgen Inc AMG 160 Update Call from ESMO Virtual Congress 2020 TranscriptSep 21, 2020
- Amgen Inc Sotorasib Update Call from ESMO Virtual Congress 2020 TranscriptSep 20, 2020
- Amgen Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Amgen Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Amgen Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2020
- Q2 2020 Amgen Inc Earnings Call TranscriptJul 28, 2020R$47.07 (-0.06%)Earnings
- Amgen Inc at BMO Capital Markets Prescription for Success Healthcare Conference (Virtual) TranscriptJun 23, 2020
- Amgen Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Amgen Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- Amgen Inc Investor Meeting at ASCO20 Virtual Scientific Program TranscriptMay 29, 2020
- Amgen Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Amgen Inc at SunTrust Robinson Humphrey Life Sciences Summit TranscriptMay 06, 2020
- Q1 2020 Amgen Inc Earnings Call TranscriptApr 30, 2020R$46.13 (+1.52%)Earnings
- Amgen Inc and Adaptive Biotechnologies Corp Webinar on Targetting Covid-19 TranscriptApr 09, 2020
- Amgen Inc at Cowen HealthCare Conference TranscriptMar 02, 2020
- Q4 2019 Amgen Inc Earnings Call TranscriptJan 30, 2020R$34.27 (-0.27%)Earnings
- Amgen Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Amgen Inc at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top TranscriptJan 09, 2020
- Amgen Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Beigene Ltd Corporate Update: Global Strategic Oncology Collaboration with Amgen TranscriptNov 01, 2019
- Amgen Inc Conference Call on the BeiGene Collaboration TranscriptOct 31, 2019
- Q3 2019 Amgen Inc Earnings Call TranscriptOct 29, 2019R$29.3Earnings
- Amgen Inc Investor Call at European Society for Medical Oncology (ESMO) TranscriptSep 28, 2019
- Amgen Inc at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 18, 2019
- Amgen Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Amgen Inc Investor Call At IASLC 2019 World Conference on Lung Cancer TranscriptSep 08, 2019
- Amgen Inc to Acquire Worldwide Rights to Otezla® from Celgene Corp - Conference Call TranscriptAug 26, 2019
- Q2 2019 Amgen Inc Earnings Call TranscriptJul 30, 2019R$23.42Earnings
- Amgen Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- Amgen Inc Investor Event at ASCO 2019 TranscriptJun 03, 2019
- Amgen Inc at UBS Global Healthcare Conference TranscriptMay 21, 2019
- Amgen Inc at RBC Capital Markets Healthcare Conference TranscriptMay 21, 2019
- Amgen Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Q1 2019 Amgen Inc Earnings Call TranscriptApr 30, 2019R$25.72Earnings
- Amgen Inc at Cowen Health Care Conference TranscriptMar 12, 2019
- Q4 2018 Amgen Inc Earnings Call TranscriptJan 29, 2019R$25.56 (-0.27%)Earnings
Amgen Inc at Bank of America Merrill Lynch Global Healthcare Conference Transcript
Sep 15, 2022 / 08:55AM GMT
Release Date Price:
R$42.55
(+1.48%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Excellent. Welcome to the BofA London Healthcare Conference. So my name is Geoff Meacham I'm a senior biopharma analyst here at BofA. And we're thrilled to have Amgen with us and up here on stage is Peter Griffith, CFO; and Arvind Sood, Senior Director of Investor Relations. So guys, welcome to the conference. Looking forward to the discussion.
Peter H. Griffith
Amgen Inc. - Executive VP & CFO
Geoff, thank you. Thanks for inviting us. We're glad to be here. Thank you, Bank of America. And I'd just like to open up with a few thoughts.
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Yes, let's do that.
Peter H. Griffith
Amgen Inc. - Executive VP & CFO
First maybe share with the group. Recall our focus on long-term growth and our sharing with the group back in February about our guidance through 2030, mid-single-digit growth, upper single-digit,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)